A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)

Completed · Phase 1/Phase 2

Conditions studied: Dementia With Lewy Bodies, Alzheimer's Disease, Parkinson's Disease

In brief

The purpose of this study is to evaluate the ability to identify individuals with dopaminergic degeneration in group of patients with a clinical diagnosis of either dementia with Lewy bodies (DLB) or idiopathic Parkinson's disease and to differentiate them from Alzheimer's disease (AD) and control subjects.

Key facts

Study ID

NCT01503944

Run by

Avid Radiopharmaceuticals

People needed

30

Starts

2010-03-01

Expected to finish

2011-07-01

Last updated by the study team

2012-08-14

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Have a history or current diagnosis of other neurologic disease
• Have evidence of clinically significant cerebrovascular disease
• Have evidence from MRI or other biomarker studies that suggests the presence of a CNS pathology other than that associated with the study diseases

Where it is running

• Research Site — Sun City, Arizona, United States
• Research Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.